Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN)

American Journal of Transplantation

Volumn 2, Issue 1, 2002, Pages 57-61

  Acker, Christopher G ^a   Flick, Richard ^a   Shapiro, Ron ^a   Scantlebury, Velma P ^a   Jordan, Mark L ^a   Vivas, Carlos ^a   Greenberg, Arthur ^a   Johnson, John P ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Acute renal failure; Delayed graft function; Thyroid hormone

Indexed keywords

3,3',5' TRIIODOTHYRONINE; CREATININE; IMMUNOSUPPRESSIVE AGENT; LIOTHYRONINE; TACROLIMUS; THYROID HORMONE; THYROTROPIN;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; CADAVER KIDNEY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EUTHYROID SICK SYNDROME; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEMODIALYSIS; HOSPITALIZATION; HUMAN; ISCHEMIA; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL ANALYSIS; THYROID FUNCTION; TREATMENT OUTCOME;

ADULT; BIOPSY; DOUBLE-BLIND METHOD; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; KIDNEY TUBULAR NECROSIS, ACUTE; MIDDLE AGED; PLACEBOS; THYROTROPIN; TIME FACTORS; TRIIODOTHYRONINE; TRIIODOTHYRONINE, REVERSE;

EID: 0036461032     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.020110.x     Document Type: Article

References (33)

1. Lechevalier E, Dussol B, Luccioni A et al. Posttransplantation acute tubular necrosis: risk factors and implications for graft survival. Am J Kidney Dis 1998; 32: 984-991.
2. Olsen S, Burdick JF, Keown PA, Wallace AC, Racusen LC, Solez K. Primary acute renal failure ('acute tubular necrosis') in the transplanted kidney: morphology and pathogenesis. Medicine 1989; 68: 173-187.
3. Cecka JM, Cho YW, Terasaki PI. Analysis of USOS scientific renal registry at 3 years: early events affecting transplant success. Transplantation 1992; 53: 59-64.
4. Sanfilippo F, Vaughn WK, Spees EK, Lucas BA. The detrimental effects of delayed graft function in cadaver donor renal transplantation. Transplantation 1984; 38: 643-648.
5. Halloran PF, Aprile MA, Farewell V et al. Early function as the principal correlate of graft survival. Transplantation 1988; 46: 223-228.
6. Howard RJ, Pfaff WW, Brunson ME et al. Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival. Transplant Proc 1993; 25: 884.
7. Mendez-Picon G, Posner MP, McGeorge MB et al. The effect of delayed function on long term survival of renal allografts. Surg Gynecol Obstet 1985; 161: 351-356.
8. Fischer J, Kirste G, Keller H, Wilms H. Does ATN influence renal transplant function negatively? Transplant Proc 1988; 20: 908-909.
9. Barry JM, Norman D, Fuchs EF, Fischer S, Bennett WM. Influence of acute tubular necrosis on first cadaver kidney transplant function. J Urol 1984; 132: 234-236.
10. Halloran P, Aprile M. Factors influencing early renal function in cadaver kidney transplants. Transplantation 1988; 45: 122-127.
11. Lipkowitz GS, Hong JH, Galishoff ML et al. Immediate post-transplant renal failure: evidence for an immunologic pathogenesis. Transplant Proc 1989; 21: 1256-1257.
12. Iwaki Y, Terasaki PI. Primary nonfunction in human cadaver kidney transplantation: evidence for hidden hyperacute rejection. Clin Transplant 1987; 1: 124-131.
13. Lytton B, Vaisbort VR, Glazier WB, Chaudry IH, Baue AE. Improved renal function using adenosine triphosphate-magnesium chloride in preservation of canine kidneys subjected to warm ischemia. Transplantation 1981; 31: 187-189.
14. Sutter PM, Thulin G, Stromski M et al. Beneficial effect of thyroxin in the treatment of ischemic acute renal failure. Pediatr Nephrol 1988; 2: 1-7.
15. Siegel NJ, Gaudio KM, Katz LA et al. Beneficial effect of thyroxin on recovery from toxic acute renal failure. Kidney Int 1984; 25: 906-911.
16. Cronin RE, Brown DM, Simonsen R. Protection by thyroxine in nephrotoxic acute renal failure. Am J Physiol 1986; 251: F408-F416.
17. Russell JD, Churchill DN. Calcium antagonists and acute renal failure. Am J Med 1989; 87: 306-315.
18. Miller SB, Martin DR, Kissane J, Hammerman MR. Rat models for clinical use of insulin-like growth factor I in acute renal failure. Am J Physiol 1994; 266: F949-F956.
19. Lieberthal W, Sheridan AM, Valeri CR. Protective effect of atrial natriuretic factor and mannitol following renal ischemia. Am J Physiol 1990; 258: F1266-F1272.
20. Wagner K, Albrecht S, Neumayaer HH. Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study. Am J Nephrol 1987; 7: 287-291.
21. Sands JM, Neylan JF, Olson RA, O'Brien DP, Whelchel JD, Mitch WE. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation. J Am Soc Nephrol 1991; 1: 1081-1086.
22. Tiggeler RG, Berden JH, Hoitsma AJ, Koene RA. Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydration. Ann Surg 1985; 201: 246-251.
23. Novitzky D, Cooper DK, Human PA, Reichart B, Zuhdi N. Triiodothyronine therapy for heart donor and recipient. J Heart Transplant 1988; 7: 370-376.
24. 4 protocol. J Urol 1992; 147: 325-326.
25. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the 'euthyroid sick syndrome'. Endocr Rev 1982; 3: 164-217.
26. Goldman L, Caldera DL, Nussbaum SR et al. Multifactoral index of cardiac risk in non cardiac surgical procedures. N Engl J Med 1977; 297: 845-850.
27. Shapiro R, Jordon M, Scantlebury V et al. A prospective, randomized trial of FK-506 in renal transplantation-a comparison between double- and triple-drug therapy. Clin Transplant 1996; 8: 508-515.
28. Klemperer JD, Klein IL, Ojamaa K et al. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg 2001; 61: 1323-1329.
29. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 1989; 344: 501-509.
30. Thistlethwaite JR, Woodle ES, Mayes JT et al. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction. Transplant Proc 1989; 21: 1890-1892.
31. Cecka JM, Terasaki PI, eds. Clinical Transplants. Los Angeles: UCLA Immunogenetics Center; 1999. pp. 1-22.
32. Acker CG, Singh AR, Flick RP, Bernardini J, Greenberg A, Johnson JP. A trial of thyroxine in acute renal failure. Kidney Int 2000; 57: 293-298.
33. Molitoris BA, Weinberg JM, Venkatachalam MA, Zager RA, Nath KA, Gologorsky MS. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol 2000; 278: F1-F12.